| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 10-Q |
| 16 Nov 2026 |
8-K: Results of Operations and Financial Condition
Date of Report (Date of earliest event reported): November 16, 2026 |
| 18 Aug 2026 |
Form 4: Lipschultz Tyler, Director
Received 215,517 shares as a grant or award |
| 18 Aug 2026 |
Form 4: Bakewell John K, Director
Received 215,517 shares as a grant or award |
| 18 Aug 2026 |
Form 4: Beeson Jonn R., Director
Received 215,517 shares as a grant or award |
| 18 Aug 2026 |
Form 4: Jain Abhinav, Director
Received 215,517 shares as a grant or award |
| 18 Aug 2026 |
Form 4: Vizirgianakis Stavros G., Director
Received 323,275 shares as a grant or award |
| 18 Aug 2026 |
Form 4: Schallenberger Mark A., Chief Operating Officer
Received 450,000 shares as a grant or award · Gave up 7,070 shares to cover exercise price or tax ($2.19K) |
| 18 Aug 2026 |
Form 4: Neils Scott C, CFO and Assistant Secretary
Received 400,000 shares as a grant or award · Gave up 28,155 shares to cover exercise price or tax ($8.73K) |
| 18 Aug 2026 |
Form 4: Browne Sean E, Director
Received 550,000 shares as a grant or award · Gave up 10,605 shares to cover exercise price or tax ($3.29K) |
| 11 Aug 2026 | 10-Q |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition
Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures |
| 07 Aug 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Xtant Medical Holdings, Inc. (the “Company”) held an Annual Meeting of Stockholders (the “Annual Meeting”) on August 7, 2026. As of the close of business on June 9, 2026, the record date for the Annual Meeting, there were 140,262,960 sha... |
| 23 Jun 2026 | ARS |
| 23 Jun 2026 | DEFA14A |
| 23 Jun 2026 |
Proxy statement: annual meeting on August 7, 2026
CEO pay $1.4M, down 45% · say-on-pay vote |
| 29 May 2026 | SD |
| 13 May 2026 | S-8 POS |
| 13 May 2026 | S-8 POS |
| 13 May 2026 | S-8 POS |
Loading...